Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Filing of New Bleeding Claim in Illinois

Share Article

The Firm is representing a number of clients whose Xarelto lawsuits put forth similar allegations regarding the drug’s association with uncontrollable internal bleeding.

Free Case Review
Our Firm is representing a number of clients who have filed Xarelto lawsuits that put forth similar allegations regarding its association with uncontrollable internal bleeding.

Xarelto lawsuits (http://www.xareltolawsuit2015.com/) filed on behalf of individuals who were allegedly harmed by the medication continue to mount in state and federal courts around the country, Bernstein Liebhard LLP reports. According to court documents, an Illinois woman filed one such claim on January 22nd in St. Clair County Circuit Court, after she allegedly suffered serious injuries due to her use of the blood thinning medication. Among other things, the complaint claims that as a result of taking Xarelto, the Plaintiff’s blood was not able to congeal in a timely manner. The lawsuit further alleges that marketing materials for Xarelto failed to highlight data from clinical trials that suggested the medication posed serious bleeding concerns, including an increased risk of gastrointestinal bleeding and bleeding that required transfusion.(Case No. 15-L-35)

“Our Firm is representing a number of clients who have filed Xarelto lawsuits that put forth similar allegations regarding its association with uncontrollable internal bleeding, and we continue to receive inquiries from individuals who claim to have experienced similar complications. It is not surprising that the litigation surrounding this drug continues to grow,” said Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free, no-obligation Xarelto case reviews to people who allegedly suffered serious injuries from the blood thinner, including uncontrollable bleeding, strokes, deep vein thrombosis or pulmonary embolism.

Xarelto Litigation
Xarelto was approved by the U.S. Food & Drug Administration in 2011, and is currently indicated to prevent strokes in people with atrial fibrillation; as a treatment for deep vein thrombosis and pulmonary embolism; and to prevent deep vein thrombosis in patients undergoing hip or knee replacement surgery. Like all blood thinners, Xarelto can sometimes cause patients to experience internal hemorrhaging. However, no antidote has yet been approved to reverse Xarelto bleeding.*

Court documents indicate that the Xarelto lawsuit pending in Illinois is just one of dozens of similar claims that have recently been filed in U.S. courts. In December 2014, all federal cases involving the drug were consolidated in a multidistrict litigation and transferred to the U.S. District Court, Eastern District of Louisiana. Among other things, these lawsuits allege the drugs’ manufacturers wrongly marketed Xarelto as a superior alternative to warfarin, a blood thinner that has been on the market for decades. According to court records, nearly 90 Xarelto bleeding claims have been filed in the proceeding thus far. (In Re: Xarelto Products Liability Litigation, No. 2592)

Individuals who suffered uncontrollable episodes of internal bleeding allegedly associated with Xarelto may be entitled to take legal action against the drug’s manufacturers. Learn more about filing a Xarelto lawsuit by visiting Bernstein Liebhard LLP’s website, or by calling 800-511-5092 to schedule a free, no obligation case review.

*fda.gov/downloads/Drugs/DrugSafety/UCM280333.pdf, FDA, March 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website